SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
22-Mar-24 5:16 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 21-Mar-24 | Sale (Planned) | 73 | $20.70 | $1,511.10 | (< 1%) 426.73K to 426.66K | |
22-Mar-24 5:16 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 21-Mar-24 | Sale (Planned) | 121 | $20.70 | $2,504.70 | (< 1%) 426.66K to 426.54K | |
22-Mar-24 5:16 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 20-Mar-24 | Sale (Planned) | 2,295 | $20.27 | $46,519.70 | (< 1%) 432.87K to 430.58K | |
22-Mar-24 5:16 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 20-Mar-24 | Sale (Planned) | 3,847 | $20.27 | $77,978.70 | (< 1%) 430.58K to 426.73K | |
11-Mar-24 5:18 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 07-Mar-24 | Sale (Planned) | 3,996 | $20.77 | $82,996.90 | (< 1%) 436.87K to 432.87K | |
11-Mar-24 5:18 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 07-Mar-24 | Sale (Planned) | 2,372 | $20.77 | $49,266.40 | (< 1%) 439.24K to 436.87K | |
06-Mar-24 10:00 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 05-Mar-24 | Option Exercise | 10,686 | $3.72 | $39,751.90 | 2% 432.69K to 443.37K | |
06-Mar-24 10:00 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 05-Mar-24 | Option Sale | 4,131 | $21.41 | $88,461.20 | (< 1%) 443.37K to 439.24K | |
09-Feb-24 4:49 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 07-Feb-24 | Sale (Planned) | 2,074 | $23.20 | $48,116.80 | (2%) 131.78K to 129.71K | |
07-Feb-24 4:19 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 06-Feb-24 | Sale (Planned) | 9,847 | $23.63 | $232,685.00 | (7%) 141.63K to 131.78K | |
07-Feb-24 4:19 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 05-Feb-24 | Sale (Planned) | 11,402 | $22.90 | $261,134.00 | (7%) 153.03K to 141.63K | |
08-Jan-24 4:19 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 05-Jan-24 | Sale (Planned) | 5,100 | $20.36 | $103,836.00 | (3%) 158.13K to 153.03K | |
08-Jan-24 4:19 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 04-Jan-24 | Sale (Planned) | 18,223 | $20.40 | $371,749.00 | (10%) 176.35K to 158.13K | |
04-Jan-24 5:16 PM View: | Juvenal Tobin W Chief Commercial Officer | Castle Biosciences Inc (CSTL) | 02-Jan-24 | Option Exercise | 6,701 | $2.89 | $19,381.40 | 16% 42.39K to 49.09K | |
03-Jan-24 4:11 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 29-Dec-23 | Option Exercise | 12,615 | $3.01 | $38,033.90 | 9% 137.69K to 150.3K | |
29-Dec-23 4:05 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 28-Dec-23 | Sale (Planned) | 3,954 | $22.17 | $87,660.20 | (< 1%) 437.2K to 433.24K | |
29-Dec-23 4:05 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 28-Dec-23 | Sale (Planned) | 557 | $22.17 | $12,348.70 | (< 1%) 433.24K to 432.69K | |
29-Dec-23 4:05 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 27-Dec-23 | Sale (Planned) | 1,137 | $21.90 | $24,900.30 | (< 1%) 438.33K to 437.2K | |
29-Dec-23 4:05 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 27-Dec-23 | Sale (Planned) | 8,076 | $21.90 | $176,864.00 | (2%) 446.41K to 438.33K | |
27-Dec-23 4:18 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 26-Dec-23 | Sale (Planned) | 5,180 | $21.93 | $113,597.00 | (1%) 452.32K to 447.14K | |
27-Dec-23 4:18 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 26-Dec-23 | Sale (Planned) | 729 | $21.93 | $15,987.00 | (< 1%) 447.14K to 446.41K | |
27-Dec-23 4:18 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 22-Dec-23 | Sale (Planned) | 5,224 | $21.96 | $114,719.00 | (1%) 458.28K to 453.05K | |
27-Dec-23 4:18 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 22-Dec-23 | Sale (Planned) | 736 | $21.96 | $16,162.60 | (< 1%) 453.05K to 452.32K | |
22-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 21-Dec-23 | Sale (Planned) | 1,549 | $21.40 | $33,153.20 | (< 1%) 459.83K to 458.28K | |
22-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 21-Dec-23 | Sale (Planned) | 10,999 | $21.40 | $235,412.00 | (2%) 470.83K to 459.83K | |
22-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 20-Dec-23 | Sale (Planned) | 5,201 | $21.05 | $109,455.00 | (1%) 476.76K to 471.56K | |
22-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 20-Dec-23 | Sale (Planned) | 733 | $21.05 | $15,426.00 | (< 1%) 471.56K to 470.83K | |
20-Dec-23 4:46 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 19-Dec-23 | Sale (Planned) | 5,719 | $20.84 | $119,161.00 | (1%) 485.79K to 480.07K | |
20-Dec-23 4:46 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 19-Dec-23 | Sale (Planned) | 3,314 | $20.84 | $69,050.50 | (< 1%) 480.07K to 476.76K | |
20-Dec-23 4:46 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 18-Dec-23 | Sale (Planned) | 5,720 | $20.27 | $115,962.00 | (1%) 493.01K to 487.29K | |
20-Dec-23 4:46 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 18-Dec-23 | Sale (Planned) | 1,498 | $20.27 | $30,369.00 | (< 1%) 487.29K to 485.79K | |
18-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 15-Dec-23 | Sale (Planned) | 1,113 | $20.21 | $22,493.70 | (< 1%) 494.12K to 493.01K | |
18-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 15-Dec-23 | Sale (Planned) | 3,709 | $20.21 | $74,958.90 | (< 1%) 497.83K to 494.12K | |
18-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 14-Dec-23 | Sale (Planned) | 286 | $21.70 | $6,206.20 | (< 1%) 498.43K to 498.15K | |
18-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 14-Dec-23 | Sale (Planned) | 8,866 | $20.86 | $184,945.00 | (2%) 516.96K to 508.1K | |
18-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 14-Dec-23 | Sale (Planned) | 314 | $21.70 | $6,813.80 | (< 1%) 498.15K to 497.83K | |
18-Dec-23 4:06 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 14-Dec-23 | Sale (Planned) | 9,662 | $20.86 | $201,549.00 | (2%) 508.1K to 498.43K | |
14-Dec-23 5:39 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 13-Dec-23 | Sale (Planned) | 3,980 | $20.21 | $80,435.80 | (< 1%) 520.94K to 516.96K | |
14-Dec-23 5:39 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 13-Dec-23 | Sale (Planned) | 3,652 | $20.21 | $73,806.90 | (< 1%) 524.59K to 520.94K | |
14-Dec-23 5:32 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 13-Dec-23 | Sale (Planned) | 1,168 | $20.04 | $23,406.70 | (< 1%) 177.52K to 176.35K | |
14-Dec-23 5:39 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 12-Dec-23 | Sale (Planned) | 546 | $20.01 | $10,925.50 | (< 1%) 525.39K to 524.85K | |
14-Dec-23 5:39 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 12-Dec-23 | Sale (Planned) | 254 | $20.01 | $5,082.54 | (< 1%) 524.85K to 524.59K | |
14-Dec-23 5:32 PM View: | Bradbury Daniel Director | Castle Biosciences Inc (CSTL) | 12-Dec-23 | Sale (Planned) | 1,200 | $20.01 | $24,012.00 | (< 1%) 178.72K to 177.52K | |
12-Dec-23 7:28 PM View: | Juvenal Tobin W Chief Commercial Officer | Castle Biosciences Inc (CSTL) | 10-Dec-23 | Option Exercise | 7,920 | -- | -- | 22% 36.4K to 44.32K | |
12-Dec-23 7:39 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 10-Dec-23 | Option Exercise | 7,920 | -- | -- | 6% 131.85K to 139.78K | |
12-Dec-23 7:33 PM View: | Stokes Frank Chief Financial Officer | Castle Biosciences Inc (CSTL) | 10-Dec-23 | Option Exercise | 8,170 | -- | -- | 24% 33.77K to 41.94K | |
12-Dec-23 7:28 PM View: | Juvenal Tobin W Chief Commercial Officer | Castle Biosciences Inc (CSTL) | 10-Dec-23 | Payment of Exercise | 1,930 | $20.17 | $38,928.10 | (4%) 44.32K to 42.39K | |
12-Dec-23 7:39 PM View: | Oelschlager Kristen M Chief Operating Officer | Castle Biosciences Inc (CSTL) | 10-Dec-23 | Payment of Exercise | 2,088 | $20.17 | $42,115.00 | (1%) 139.78K to 137.69K | |
12-Dec-23 7:33 PM View: | Stokes Frank Chief Financial Officer | Castle Biosciences Inc (CSTL) | 10-Dec-23 | Payment of Exercise | 2,386 | $20.17 | $48,125.60 | (6%) 41.94K to 39.55K | |
12-Dec-23 7:23 PM View: | Maetzold Derek J Pres. & Chief Exec. Officer Director | Castle Biosciences Inc (CSTL) | 10-Dec-23 | Option Exercise | 20,787 | -- | -- | 4% 511.09K to 531.87K |